Evaluation of the anti-inflammatory effect of erythromycin on aseptic inflammation of temporomandibular joint in rabbit: A scintigraphic and histopathologic study

Dental Traumatology

Volumn 21, Issue 4, 2005, Pages 213-217

  Ertaş, Ümit ^a   Tozoglu, Sinan ^a   Sahin, Onder ^a   Seven, Bedri ^a   Gundogdu, Cemal ^a   Aktan, Bulent ^b   Yildirim, Mustafa ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

Author keywords

Erythromycin; Tc 99 m HIG scintigraphy; TMJ inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; DIAGNOSTIC AGENT; ERYTHROMYCIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RADIOPHARMACEUTICAL AGENT; SODIUM CHLORIDE; TECHNETIUM; TECHNETIUM TC 99M IMMUNOGLOBULIN;

ANIMAL; ARTHRITIS; ARTICLE; DRUG EFFECT; EPITHELIUM; FACE MUSCLE; IMAGE PROCESSING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; PATHOLOGY; RABBIT; SCINTISCANNING; SYNOVIUM; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS; EPITHELIUM; ERYTHROMYCIN; FACIAL MUSCLES; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOGLOBULINS; INJECTIONS, INTRAPERITONEAL; MALE; METHYLPREDNISOLONE; RABBITS; RADIOPHARMACEUTICALS; SODIUM CHLORIDE; SYNOVIAL MEMBRANE; TECHNETIUM; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 23144440622     PISSN: 16004469     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-9657.2005.00294.x     Document Type: Article

References (21)

1. Fonseca RJ. Oral and maxillofacial surgery, Vol. 4. Philadelphia, PA: W.B. Saunders Company; 2000. p. 73-92.
2. Okeson JP. Management of temporomandibular disorders and occlusion, 4th edn. St Louis: Mosby; 1998. p. 436-45.
3. Kaplan AS, Assael LA. Temporomandibular disorders: diagnosis and treatment. Philadelphia, PA: W.B. Saunders Company; 1991. p. 106-97.
4. Chambers HF. Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Hardman JG, Limbird LE, editors. The pharmacological basis of therapeutics, 10th edn. New York: McGraw-Hill; 2001. p. 1239-71.
5. Ianora A, Ialenti A, Maffia P, Sautebin L, Rombola L, Carnuccio R et al. Anti-inflammatory activity of macrolides antibiotics. J Pharmacol Exp Ther 2000;292:156-63.
6. Boerman OC, Rennen H, Oyen WJ, Corstens FH. Radiopharmaceuticals to image infection and inflammation. Semin Nucl Med 2001;31:286-95.
7. Boerman OC, Dams ET, Oyen WJ, Corstens FH, Storm G. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation. Inflamm Res 2001;50:55-64.
8. Oyen WJG, Boerman OC, Corstens FHM. Animal models of infection and inflammation and their role in experimental nuclear medicine. J Microbiol Method 2001;47:151-7.
9. Gencoglu EA, Aras G, Kucuk O, Atay G, Tutak I, Ataman S et al. Utility of Tc-99 m human polyclonal immunoglobulin G scintigraphy for assessing the efficacy of Yttrium-90 silicate therapy in rheumatoid knee synovitis. Clin Nucl Med 2002;27:395-400.
10. Swift JQ, Roszkowski MT, Alton T, Hargreaves KM. Effect of intra-articular versus systemic anti-inflammatory drugs in a rabbit model of temporomandibular joint inflammation. J Oral Maxillofac Surg 1998;56:1288-95.
11. Suleyman H, Demirezer LÖ, Kuruuzum A, Banoglu ZN, Gocer F, Ozbakis G et al. Anti-inflammatory effects of the aqueous extract from Rumex patientia L. roots. J Ethnopharmacol 1999;65:141-8.
12. Ichikawa Y, Ninomiya H, Koga H, Tanaka M, Kiroshita M, Tokunaga N et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992;146:196-203.
13. Cervin A. The anti-inflammatory effect of erythromycin and its derivates, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol 2001;121:83-92.
14. Takahashi Y, Shimizu T, Sakakura Y. Effects of indomethacin, dexamethasone, and erythromycin on endotoxin-induced intraepithelial mucus production of rat nasal epithelium. Ann Otol Rhinol Laryngol 1997;106:683-7.
15. Rhee CS, Majima Y, Arima S, Jung HW, Jinn TH, Min YG et al. Effects of clarythromycin on rheological properties of nasal mucus in patients with chronic sinusitis. Ann Otol Rhinol Laryngol 2000;109:484-7.
16. Berna L, Torres G, Diez C, Estorch M, Martinez-Duncker D, Carris I. Tc-99 m HIG studies and conventional bone scans to detect active joint inflammation in chronic RA. Eur J Nucl Med 1992;19:173-6.
17. Van Der Lubble PAHM, Arndt JW, Calame W, Ferreira TC, Pauwels EK, Breedveld FC. Measurement of synovial inflammation in rheumatoid arthritis with Tc-99 m labeled human polyclonal immunoglobulin G. Eur J Nucl Med 1991;18:119-23.
18. Breedveld FC, Kroonenburgh MJPG, Camps JAJ, Feitsma HI, Markusse HM, Pauwels EK. Imaging of inflammatory arthritis with Tc-99 m labeled IgG. J Nucl Med 1989;30:2017-21.
19. Liberatore M, Clemente M, Iurilli AP, Zorzin L, Marini M, Di Rocco E et al. Scintigraphic evaluation of disease activity in rheumatoid arthritis: a comparison of Tc-99 m HIG, leucocytes and albumin nanocolloid. Eur J Nucl Med 1992;19:853-7.
20. De Bois MHW, Arndt JW, Van Der Velde EA, Pauwels EK, Breedveld FC. Joint scintigraphy for quantification of synovitis with Tc-99 m HIG compared to late phase scintigraphy with Tc-99 m diphosphonate. Br J Rheum 1994;33:67.
21. Pons F, Moya F, Herranz R, Sola M, Del Olmo JA, Piera C et al. Detection and quantitative analysis of joint activity inflammation with 99Tcm-polyclonal human immunoglobulin G. Nucl Med Commun 1993;14:225.